Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (scFv-Fc) (BSCFV-171)

Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-IL12 specificity or anti-IL18 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Arthritis therapy.

Datasheet INQUIRY

Specifications

Targets

IL12 & IL18

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Arthritis

Targets

Target 1

IL12

Gene ID

3592

UniProt ID

P29459

Alternative Names

P35; CLMF; NFSK; NKSF1; IL-12A; IL12; IL-12; interleukin 12A

Target 2

IL18

Gene ID

3606

UniProt ID

A0A024R3E0

Alternative Names

IGIF; IL-18; IL-1g; IL1F4; interleukin 18; IL18

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (scFv-Fc) (BSCFV-171). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL12 x Anti-IL18 Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-171)

Specifications

Targets

Customer Reviews and Q&As